| Not Yet Recruiting | Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients W Metastatic Colorectal Cancer (CRC), Antineoplastic Agents, Immunological, VEGFR-TKI | N/A | 2026-03-01 |
| Not Yet Recruiting | Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or Metastatic Colorectal Carcinoma (mCRC) | Phase 2 | 2025-12-31 |
| Recruiting | Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocar Metastatic Oesogastric Adenocarcinoma | Phase 3 | 2025-12-15 |
| Not Yet Recruiting | PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | 2025-10-30 |
| Not Yet Recruiting | 5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Pat Colorectal Carcinoma, KRAS G12C Mutation, Unresectable Colorectal Cancer | Phase 2 | 2025-08-31 |
| Recruiting | A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers Hepatocholangiocarcinoma, Fibrolamellar Carcinoma, Hepatic Epithelioid Hemangioendothelioma | — | 2024-03-26 |
| Recruiting | Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradi Anal Cancer | Phase 3 | 2024-02-26 |
| Recruiting | Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With M Colorectal Cancer Metastatic, Microsatellite Instability-High Colorectal Cancer | — | 2024-02-12 |
| Completed | Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patien HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor | Phase 2 / Phase 3 | 2023-03-09 |
| Recruiting | Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Re Colorectal Cancer, BRAF V600E Mutation Positive | Phase 2 | 2023-02-13 |
| Recruiting | Cohort of Tumors With POLE/D1 Mutation Tumors, POLE Exonuclease Domain Mutation, POLD1 Gene Mutation | — | 2021-10-05 |
| Unknown | Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate Colorectal Cancer Metastatic, High Immune Infiltrate, Microsatellite Stable | Phase 2 | 2021-04-06 |
| Unknown | Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atez Metastatic Colorectal Cancer, pMMR, MSS | Phase 2 | 2020-10-07 |
| Completed | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients Cancer, COVID, Solid Tumor | — | 2020-04-03 |
| Active Not Recruiting | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatme Gastric Adenocarcinoma, Gastric Cancer | Phase 2 | 2019-07-17 |
| Completed | Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Squamous Cell Carcinoma | Phase 2 | 2019-03-07 |
| Active Not Recruiting | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junct Stomach Cancer, Stomach Neoplasm, Gastric Cancer | Phase 2 | 2018-11-16 |
| Completed | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen o Metastatic Pancreatic Cancer | Phase 2 | 2018-11-16 |
| Completed | FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Flu Metastatic Colorectal Cancer | Phase 2 | 2018-04-26 |
| Completed | Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer Metastatic Colorectal Cancer, MSI | Phase 2 | 2018-04-24 |
| Unknown | Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma Ampullary Adenocarcinoma | — | 2017-07-07 |
| Active Not Recruiting | National Cohort of Colorectal Cancers With Microsatellite Instability Colorectal Cancer, Microsatellite Instability | — | 2017-03-22 |
| Completed | PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LO OESOPHAGO-GASTRIC CARCINOMA | Phase 3 | 2016-12-19 |
| Recruiting | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy Colorectal Neoplasms | Phase 3 | 2016-12-01 |
| Terminated | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colore Colorectal Neoplasms | Phase 2 | 2016-09-01 |
| Unknown | Study of the Practice of Debiri in France Colorectal Adenocarcinoma, Hepatic Metastases | — | 2016-02-03 |
| Completed | Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenoc Colorectal Adenocarcinoma | Phase 2 | 2016-01-01 |
| Completed | Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus Epidermoid Carcinoma, Anus | Phase 1 / Phase 2 | 2016-01-01 |
| Completed | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab Metastatic Pancreatic Cancer | Phase 2 | 2015-11-01 |
| Completed | Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers Colorectal Neoplasms | Phase 2 | 2015-05-01 |
| Completed | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem Metastatic Pancreatic Cancer | Phase 2 | 2015-01-12 |
| Completed | Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - I Liver Cancer | Phase 2 | 2015-01-01 |
| Terminated | A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroe Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours | Phase 2 / Phase 3 | 2015-01-01 |
| Recruiting | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patie Colonic Adenocarcinoma | Phase 3 | 2015-01-01 |
| Completed | Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients Metastatic Colorectal Cancer | Phase 2 | 2014-10-01 |
| Completed | Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Non Resectable Hepatic Metastasis | Phase 2 | 2013-05-01 |
| Completed | Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors Neuroendocrine Tumors, Hepatic Metastases, Metastases | Phase 2 | 2012-12-01 |
| Completed | First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasi Adenocarcinoma of Rectum | Phase 2 | 2012-04-01 |
| Completed | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2011-07-01 |
| Completed | Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Sto Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | Phase 2 | 2011-06-01 |
| Completed | Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Pancreatic Cancer | Phase 2 | 2011-06-01 |
| Completed | Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer Liver Cancer | Phase 2 / Phase 3 | 2010-07-01 |
| Completed | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients Colorectal Cancer | Phase 2 / Phase 3 | 2010-03-01 |
| Completed | Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis Liver Cancer | Phase 3 | 2010-02-01 |
| Terminated | Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis Liver Cancer | Phase 2 | 2010-01-01 |
| Completed | Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage II Colorectal Cancer | Phase 3 | 2009-09-01 |
| Withdrawn | Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Recta Colorectal Cancer, Metastatic Cancer | Phase 2 | 2009-04-01 |
| Completed | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Colorectal Cancer | Phase 2 | 2007-11-01 |
| Completed | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Esophageal Cancer | Phase 1 / Phase 2 | 2007-07-01 |
| Completed | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2007-01-01 |
| Unknown | Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Me Colorectal Cancer | Phase 2 | 2006-06-01 |
| Completed | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was C Colorectal Cancer | Phase 3 | 2005-11-01 |
| Completed | Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas Metastatic Colorectal Cancer | — | 2005-11-01 |
| Completed | Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmet Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer | Phase 2 / Phase 3 | 2005-10-01 |
| Completed | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surg Pancreatic Cancer | Phase 3 | 2005-10-01 |
| Unknown | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Colorectal Cancer | Phase 3 | 2004-06-01 |
| Completed | Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroe Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome | Phase 2 | 2004-05-01 |
| Completed | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer Th Colorectal Cancer | Phase 3 | 2003-06-01 |
| Completed | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer Esophageal Cancer | Phase 3 | 2002-05-01 |
| Completed | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetast Pancreatic Cancer | Phase 3 | 2000-03-01 |
| Completed | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer | Phase 3 | 1993-04-01 |
| Completed | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advan Esophageal Cancer | Phase 3 | — |